Jack Kruse nnEMF Claims Graded: IARC 2B Reality vs Mitochondrial Poison Hierarchy

EMF risk communication fails in two directions: pretending IARC said nothing, and pretending IARC rewrote the entire disease hierarchy around your router.

This article is informational and editorial only. It is not medical advice, diagnosis, or a treatment plan. Numbers and literature ranges cited here are not personal prescriptions. Consult a qualified clinician before changing medications, supplements, diet, equipment, or management of a diagnosed condition. Seek urgent care for emergencies.

What does Kruse assert about grids, light, and wireless?

About-page narratives place power-grid era electrification and man-made light at the start of mitochondrial disease stories, with artificial EM spectrum between Schumann resonance bands and infrared framed as a modern ills zone. Leptin Rx curriculum points readers into EMF quantum posts as required reading.

Secondary summaries claim nnEMFs dehydrate cells, distort water chemistry, and confuse mitochondria. Grade the clinical leap separately from the existence of anthropogenic fields.

How do IARC and ICNIRP actually bound the topic?

IARC 2011 RF Group 2B rests on limited human evidence and limited animal evidence combinations—not a verdict that typical phone use is proven cancer at ordinary exposures. ICNIRP 2020 RF guidelines cover a wide frequency range with basic restrictions and reference levels for established effects.

Hazard class, exposure compliance, and individual epidemiologic risk are three different questions. Collapsing them produces slogan science.

Where is literature polarized?

Non-thermal findings and process critiques of WHO/ICNIRP appear in contested papers; mainstream agency positions still center established effects for limits. That polarization is real and does not automatically elevate any single clinician’s total disease model to consensus.

No major regulator adopts light–water–magnetism hierarchies as primary care standards for metabolic disease.

What practical dual-source stack remains?

Protect sleep from late screens; use speakerphone or distance if desired; avoid distracted driving; prioritize food, training, and sleep over unvalidated EMF detox commerce. State IARC 2B accurately without fear upgrades or all-clears that invent Group 4 language IARC did not issue for RF.

Sources: IARC PR208 RF Group 2B; ICNIRP RF Guidelines 2020; Kruse about / grid narrative.

Readers should dual-source primary literature, translate slogans into exposure units and effect sizes, and rank interventions by expected value under uncertainty. Cheap reversible steps often outrank extreme protocols. Opportunity cost is real: hours spent on unvalidated tests are hours not spent on sleep, training, protein adequacy, and primary care. Sex, life stage, comorbidities, medications, and geography change interpretation. Prefer falsifiable claims with named endpoints over multi-disease cure lists. Update beliefs when stronger trials appear rather than freezing identity around a single paper or influencer narrative. Measured curiosity beats both panic and complacency. Further reading should prioritize primary sources and consensus documents over secondary social summaries. When evidence is mixed, state both the signal and the limits in the same paragraph. When evidence is strong, still avoid overclaiming universality across populations.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes.

Context, dose, endpoint, and population must travel together; slogans that drop any of those four are not finished claims. Log what you actually do for four weeks before declaring a protocol superior or useless. Recovery, protein, and progressive overload remain the durable levers for most training outcomes.